Drug safety and pharmacovigilance

Drug safety and pharmacovigilance

CAPA Cases in Pharmacovigilance: An Overview

In this detailed blog, we explore into CAPA cases, their workflow, and their significance within pharmacovigilance. Explore further to gain a deeper understanding of how to effectively manage CAPA within this context.

Bala

Read

Drug safety and pharmacovigilance

❇ Thalidomide incident and pharmaceutical industry

Welcome to our comprehensive blog where we delve into the transformative impact of thalidomide and its lasting influence on the cost burden of drugs in our society today. Gain a deep understanding of how the incident reshaped the way we approach drug development, testing, and regulation.

Bala

Read

Drug safety and pharmacovigilance

🖇️ Understanding Temporal Relationships in Pharmacovigilance

In this comprehensive blog post, we explore into the concept of temporal relationships within pharmacovigilance, particularly focusing on assessing causality. The discussion includes important insights and illustrative examples to enhance understanding.

Bala

Read

Drug safety and pharmacovigilance

Risk Management in Pharmacovigilance (RMP)

This blog refers to the importance of risk management in pharmacovigilance and explore its definitions and significance. We highlight how a robust risk management plan plays a vital role in ensuring the safety and effectiveness of pharmaceutical products.

Bala

Read

Drug safety and pharmacovigilance

ICSR Safety Data Exchange: The E2B

In this pharmacovigilance blog, where we delve deep in to understanding E2b, the definitions and meanings and why is it important consideration in pharmacovigilance. Contrary to common misconceptions that perceive E2B as an error format, we unveil its true nature and significance.

Bala

Read

Drug safety and pharmacovigilance

Special Scenarios in Pharmacovigilance

In this comprehensive blog, we delve into reported special scenarios within the realm of pharmacovigilance. Our exploration encompasses detailed definitions of each scenario and outlines typical situations associated with them.

Bala

Read

Drug safety and pharmacovigilance

Understanding Day-Zero(0) in Pharmacovigilance

In this comprehensive blog, you’ll uncover key information about what “Day Zero” signifies in the context of case processing and the broader field of pharmacovigilance. Additionally, you’ll gain insights into calculating the day of submissions.

Bala

Read

Drug safety and pharmacovigilance

Challenge Assessments: Exploring Dechallenge and Rechallenge

In this detailed blog post, we explore into the intricate differences between the terms “dechallenge” and “rechallenge,” providing key considerations. Learn deeper by clicking here.

Bala

Read